Dr. Rita Colwell is Distinguished University Professor at the University of Maryland at College Park and Founder of CosmosID, Inc. Her interests are focused on global infectious diseases, water, and health. She has authored or co-authored 20 books and more than 800 scientific publications. Dr. Colwell served on the National Science Board and as the 11th Director of the National Science Foundation. Dr. Colwell is a member of the National Academy of Sciences, Royal Swedish Academy of Sciences, Royal Society of Canada, Royal Irish Academy, American Academy of Arts and Sciences, and American Philosophical Society. She has been awarded 63 honorary degrees and is the recipient of the US National Medal of Science, Japan Order of the Rising Sun, Gold and Silver Star, Stockholm Water Prize, Chevalier de la Légion d’Honneur, and Lee Kuan Yew Water Prize of Singapore.
Rita Colwell, Johns Hopkins Bloomberg School of Public Health
Manoj Dadlani, CosmosID
Understanding mechanism of action and translating microbiome science into commercially viable therapeutics remains the biggest challenge in this emerging field. With that said, pharma and biotech across many different therapeutic indications and modalities are united in this global effort to bring novel microbiome-based therapies and diagnostics into the clinical domain. This session will include some of the most impactful and promising areas of the Microbiome field and panel discussions on the challenges for faster adoption.
The PMWC 2022 Microbial Profiling Showcase will provide a 15-minute time slot for selected companies in the Microbiome and Pathogen ID fields. The human microbiome is composed of a wide variety of microorganisms that are essential for maintaining human health and preventing disease. Research in this area is accelerating due to the rapid development in genome sequencing technologies. This showcase will present some of the leading companies in microbial profiling and pathogen identification.